Haleon: Perbedaan antara revisi

Jelajahi riwayat secara interaktif

← Revisi sebelumnya

Konten dihapus Konten ditambahkan

VisualTeks wiki

Revisi per 15 Agustus 2023 05.27 sunting Alex Neman (bicara \| kontrib) 14.701 suntingan k →Merek ← Revisi sebelumnya		Revisi terkini sejak 9 November 2024 06.13 sunting balikkan Astrinko (bicara \| kontrib) 1.609 suntingan Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan
(22 revisi perantara oleh 7 pengguna tidak ditampilkan)
Baris 1: {{Expand language\|topic=\|langcode=en\|otherarticle=Haleon\|date=November 2024}} {{Kembangkan\|date=November 2024}} {{Infobox company \| name = Haleon plc Baris 9 ⟶ 12: \| traded_as = {{ubl\|{{lse\|HLN}}\|{{nyse\|HLN}}\|[[FTSE 100]] component}} \| ISIN = GB00BMX86B70 \| predecessor = GSK Consumer Healthcare<br/>Pfizer Consumer Healthcare \| area_served = Seluruh dunia \| key_people = {{plainlist\| Baris 26 ⟶ 29: * [[Caltrate]] * [[Centrum (multivitamin)\|Centrum]] * [[ChapStick]] * Contac * [[Emergen-C]] Baris 70 ⟶ 72: Sir [[Dave Lewis (pengusaha)\|David Lewis]] adalah [[ketua]], dengan Brian McNamara sebagai CEO.<ref name="haleonsky">{{Cite news\|last=Kleinman\|first=Mark\|date=3 Mei 2022\|title=GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks\|url=https://news.sky.com/story/gsks-45bn-panadol-and-sensodyne-maker-haleon-in-talks-to-hire-banks-12604875\|work=[[Sky News]]\|access-date=10 Juni 2022\|archive-date=2023-02-11\|archive-url=https://web.archive.org/web/20230211180519/https://news.sky.com/story/gsks-45bn-panadol-and-sensodyne-maker-haleon-in-talks-to-hire-banks-12604875\|dead-url=no}}</ref> Haleon terdaftar di [[Bursa Efek London\|London Stock Exchange]] dan merupakan komponen dari [[Indeks FTSE 100\|FTSE 100]], dengan listing sekunder di [[Bursa Efek New York\|New York Stock Exchange]]. Penjualan tahunan berjumlah sekitar £10 miliar di 120 pasar pada tahun 2020.<ref name="forbes12">{{Cite news\|last=Cornell\|first=Joe\|date=15 July 2021\|title=GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022\|url=https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0\|work=[[Forbes]]\|access-date=10 Juni 2022\|archive-date=2023-02-11\|archive-url=https://web.archive.org/web/20230211180517/https://www.forbes.com/sites/joecornell/2021/07/15/glaxosmithkline-to-spin-off-consumer-healthcare-business-by-mid-2022/?sh=723ac83372d0\|dead-url=no}}</ref> Di Indonesia, Haleon beroperasi di bawah dua perusahaan yaitu '''PT Sterling Products Indonesia''' yang mengemas dan merilis Panadol serta Scott's Emulsion, dan '''PT Haleon Indonesia Trading''' (sebelumnya bernama '''PT GSK Consumer Healthcare Indonesia''') yang mendistribusikan Sensodyne serta Polident. == Sejarah == Baris 78 ⟶ 82: [[Unilever]] menawarkan £50 miliar untuk bisnis tersebut pada tahun 2022, dalam tawaran yang ditolak GSK.<ref name="guardian1">{{Cite news\|last=Jolly\|first=Jasper\|date=19 Januari 2022\|title=Unilever will not increase £50bn offer for GSK consumer arm\|url=https://www.theguardian.com/business/2022/jan/19/unilever-will-not-increase-50bn-offer-for-gsk-consumer-arm\|work=[[The Guardian]]\|access-date=10 Juni 2022\|archive-date=2022-10-18\|archive-url=https://web.archive.org/web/20221018002210/https://www.theguardian.com/business/2022/jan/19/unilever-will-not-increase-50bn-offer-for-gsk-consumer-arm\|dead-url=no}}</ref> [[Nestlé]] mengkaji kemungkinan penawaran bersama dengan [[Reckitt Benckiser\|Reckitt]].<ref name="bloomberg1">{{Cite news\|date=25 Mei 2022\|title=Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit\|url=https://www.bloomberg.com/news/articles/2022-05-25/nestle-eyed-biggest-ever-deal-in-aborted-move-for-gsk-consumer#xj4y7vzkg\|work=[[Bloomberg News]]\|access-date=10 Juni 2022\|archive-date=2023-04-30\|archive-url=https://web.archive.org/web/20230430142405/https://www.bloomberg.com/news/articles/2022-05-25/nestle-eyed-biggest-ever-deal-in-aborted-move-for-gsk-consumer#xj4y7vzkg\|dead-url=no}}</ref> Usulan spin-off merek perawatan bibir [[ChapStick]] senilai $600 juta diperdebatkan pada tahun 2023.<ref name="bloomberg2">{{Cite news\|last=Tse\|first=Crystal\|last2=Nair\|first2=Dinesh\|last3=David\|first3=Ruth\|date=24 Februari 2023\|title=GSK Spinoff Haleon Explores Potential $600 Million Sale of ChapStick Brand\|url=https://archive.phtoday/~~lPFZo~~20230224231835/https://www.bloomberg.com/news/articles/2023-02-24/gsk-spinoff-haleon-is-said-to-explore-sale-of-chapstick-brand?leadSource=uverify%20wall#selection-3471.0-3471.74\|work=Bloomberg\|access-date=28 Februari 2023}}</ref> == Operasi== Baris 86 ⟶ 90: == Merek == {{Multiple image \| align = right \| direction = horizontal \| total_width = 300 [[Berkas:GSK logo 2014.svg\|jmpl\|150px\|Logo GSK (2014-2022) sebelum pemisahan bisnis produk perawatan kesehatan konsumen membentuk Haleon]]▼ \| image1 = GSK logo 2014.svg \| image2 = Pfizer.svg ▲~~[[Berkas:GSK~~\| ~~logo~~footer = ~~2014.svg\|jmpl\|150px\|~~Logo GSK (kiri, 2014-2022) dan Pfizer (kanan, 2009-2021) sebelum pemisahan bisnis produk perawatan kesehatan konsumen membentuk Haleon]] }} [[Berkas:Panadol.JPG\|jmpl\|Kemasan lama Panadol, obat [[parasetamol]] yang diproduksi oleh PT Sterling Products Indonesia dibawah lisensi dari GSK (sekarang Haleon)]] Merek meliputi:<ref>{{Cite web\|title=Our Consumer Healthcare Brands\|url=https://www.haleon.com/our-brands/\|publisher=Haleon\|access-date=19 Juli 2022\|archive-date=2023-08-02\|archive-url=https://web.archive.org/web/20230802200854/https://www.haleon.com/our-brands\|dead-url=no}}</ref> Baris 149 ⟶ 158: * [[Synthol (mouthwash)\|Synthol]] (kesehatan mulut) * Theraflu (Pernafasan) * Triaminic * [[Tums\|Tum]] (pencernaan) * Viva (vitamin dan natural), asal: [[Nepal]]